Triple diagnosis: Dual diagnosis and HIV disease, Part 1

Antoine B. Douaihy, Roger J. Jou, Tad Gorske, Ihsan M. Salloum

Research output: Contribution to journalReview articlepeer-review

37 Scopus citations


Substance use disorders and psychiatric illness commonly co-occur in what is known as dual diagnosis. With the spread of HIV infection in persons with dual diagnoses, the triple diagnosis has emerged as a clinically challenging condition for primary care physicians, addiction medicine specialists, and psychiatrists. Existing data support the high prevalence of triple-diagnosis patients in psychiatric, substance abuse, and HIV treatment settings. This review highlights the features of substance abuse-psychiatric illness and its association with changes in antiretroviral therapy use, adherence, and HIV treatment outcomes. An integrated and interdisciplinary approach addressing substance abuse and mental health issues should be a primary element of comprehensive HIV care. Evaluating the safety and efficacy of psychopharmacologic and psychotherapeutic interventions and understanding the complex interactions among the components of the triple diagnosis are areas for future research. Service delivery and intervention models based on "1-stop shopping" should be developed and put into practice in order to optimize clinical outcomes.

Original languageEnglish (US)
Pages (from-to)331-332+339-341
JournalAIDS Reader
Issue number7
StatePublished - Jul 1 2003
Externally publishedYes


  • Injection drug use
  • Integrated treatment
  • Psychiatric disorder
  • Substance use disorder
  • Triple diagnosis

ASJC Scopus subject areas

  • Virology
  • Medicine(all)


Dive into the research topics of 'Triple diagnosis: Dual diagnosis and HIV disease, Part 1'. Together they form a unique fingerprint.

Cite this